ACIP releases options paper on innovation patents


Thursday, 05 September, 2013

The Advisory Council on Intellectual Property (ACIP) has just released an Options Paper for its Review of the Innovation Patent System.

ACIP is seeking stakeholder comments on policy issues that address the full range of possibilities for the innovation patent system: from abolition of the entire system to waiting to see how the recent intellectual property legislative changes bed down.

ACIP says it will further analyse these options once it has received stakeholder feedback. Submissions close on 4 October 2013.

Public roundtable discussions are planned for Brisbane, Sydney and Melbourne during September 2013. Please contact ACIP if you would like to attend one of these roundtables.

The ACIP Working Group conducting this review invites interested stakeholders to attend one of three roundtable discussions on this review. Each of the discussions will explore the policy issues and various options presented in Chapter 5 of the Options Paper. The roundtables will run from 10 am to noon in the AusIndustry meeting rooms in Sydney, Brisbane and Melbourne as follows:

  • Friday, 12 September 2013 at Level 5, 341 George St, Sydney
  • Tuesday, 17 September 2013 at Level 12, 100 Creek St, Brisbane
  • Friday, 20 September 2013 at Level 5, 111 Bourke St, Melbourne

Please note that places are limited at each of these roundtables. Interested stakeholders are encouraged to register at their earliest convenience.

More information on this ACIP review is available from http://www.acip.gov.au/reviews/all-reviews/review-innovation-patent-system/ and the Options Paper can be found at http://www.acip.gov.au/pdfs/Options_Paper_Innovation_Patent_Review.pdf.

Related News

Targeting the stress system reduces Parkinson's tremors

The commonly used Parkinson's drug levodopa usually helps with tremors, but it tends to be...

DDX53 gene linked to autism spectrum disorder

While DDX53, located on the X chromosome, is known to play a role in brain development...

ADHD drug shows promise for treating meth addiction

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd